LOXL2 deletion triggers TMJ osteoarthritis, while overexpression protects it from NF-κB-induced chondrocyte apoptosis

Abstract

Temporomandibular joint osteoarthritis (TMJ-OA) affects a significant proportion of the population worldwide. However, there has been no substantial progress in the development of FDA-approved drugs for treatment due to a lack of understanding of the specific factors regulating key TMJ-OA molecular mechanisms. Lysyl Oxidase-Like-2 (LOXL2) promotes knee joint cartilage protection and is downregulated in a TMJ-OA animal model. We evaluated the role of LOXL2 in TMJ cartilage, its molecular mechanism, and gene networks using in vivo Loxl2 knockout mice (Acan-Cre; Loxl2^flox/flox) and ex vivo goat TMJ cartilage. Our results show that Loxl2 knockout in mouse cartilage upregulates Il1b, Mmp9, Mmp13, Adamts4, and Adamts5, but reduces the levels of aggrecan and proteoglycan. Loxl2 deleted TMJ cartilage show a higher enrichment of inflammatory response, TNFA signaling via NF-κB, extracellular matrix (ECM), and collagen degradation pathway network. Conversely, LOXL2 treatment reduces interleukin-1 beta (IL-1β)-induced expression of Mmp13, protects mitochondrial function, and ECM from degeneration. Importantly, LOXL2 attenuates IL-1β-induced chondrocyte apoptosis via the phosphorylation of NF-κB and expression of the pain-related gene PTGS2 (encodes COX2). Taken together, Loxl2 knockout mice exacerbate TMJ-OA through cartilage/ECM degradation, mitochondrial dysfunction, chondrocyte apoptosis, and inflammatory gene expression, whereas LOXL2 treatment mitigate these effects.

References

[1] Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N. Engl. J. Med., 2008, 359: 2693-2705

[2] Velly AMet al.. The feasibility of a clinical trial of pain related to temporomandibular muscle and joint disorders: the results of a survey from the Collaboration on Networked Dental and Oral Research dental practice-based research networks. J. Am. Dent. Assoc., 2013, 144: e1-10

[3] Embree MCet al.. Exploiting endogenous fibrocartilage stem cells to regenerate cartilage and repair joint injury. Nat. Commun., 2016, 7 13073

[4] Worthley DLet al.. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell, 2015, 160: 269-284

[5] Jiang Y, Tuan RS. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat. Rev. Rheumatol., 2015, 11: 206-212

[6] Wei, Y. et al. Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci. Transl. Med.13, https://doi.org/10.1126/scitranslmed.abb3946 (2021).

[7] Lee, M. S. et al. Comparative evaluation of isogenic mesodermal and ectomesodermal chondrocytes from human iPSCs for cartilage regeneration. Sci. Adv.7, https://doi.org/10.1126/sciadv.abf0907 (2021).

[8] Shibata S, Fukada K, Suzuki S, Yamashita Y. Immunohistochemistry of collagen types II and X, and enzyme-histochemistry of alkaline phosphatase in the developing condylar cartilage of the fetal mouse mandible. J. Anat., 1997, 191(Pt 4): 561-570

[9] Purcell Pet al.. Temporomandibular joint formation requires two distinct hedgehog-dependent steps. Proc. Natl. Acad. Sci. USA, 2009, 106: 18297-18302

[10] Gu S, Wei N, Yu L, Fei J, Chen Y. Shox2-deficiency leads to dysplasia and ankylosis of the temporomandibular joint in mice. Mech. Dev., 2008, 125: 729-742

[11] Yasuda Tet al.. Sulfotransferase Ndst1 is needed for mandibular and TMJ development. J. Dent. Res., 2010, 89: 1111-1116

[12] Tashkandi, M. et al. Lysyl oxidase-like 2 protects against progressive and aging related knee joint osteoarthritis in mice. Int. J. Mol. Sci.20, https://doi.org/10.3390/ijms20194798 (2019).

[13] Hadidi P, Cissell DD, Hu JC, Athanasiou KA. Temporal development of near-native functional properties and correlations with qMRI in self-assembling fibrocartilage treated with exogenous lysyl oxidase homolog 2. Acta Biomater., 2017, 64: 29-40

[14] Makris EA, Responte DJ, Paschos NK, Hu JC, Athanasiou KA. Developing functional musculoskeletal tissues through hypoxia and lysyl oxidase-induced collagen cross-linking. Proc. Natl. Acad. Sci. USA, 2014, 111: E4832-4841

[15] Tosa Iet al.. Bulk RNA-seq analyses of mandibular condylar cartilage in a post-traumatic TMJ osteoarthritis rabbit model. Orthod. Craniofacial Res., 2023, 26(Suppl 1): 131-141

[16] Chow YY, Chin KY. The role of inflammation in the pathogenesis of osteoarthritis. Mediat. Inflamm., 2020, 2020: 8293921

[17] Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct. Target. Ther., 2017, 2 17023

[18] Catheline SEet al.. IKKbeta-NF-kappaB signaling in adult chondrocytes promotes the onset of age-related osteoarthritis in mice. Sci. Signal., 2021, 14 eabf3535

[19] Al-Roub Aet al.. TNFalpha induces matrix metalloproteinase-9 expression in monocytic cells through ACSL1/JNK/ERK/NF-kB signaling pathways. Sci. Rep., 2023, 13 14351

[20] Qi, Z., Zhu, J., Cai, W., Lou, C. & Li, Z. The role and intervention of mitochondrial metabolism in osteoarthritis. Mol. Cell. Biochem.https://doi.org/10.1007/s11010-023-04818-9 (2023).

[21] Mao X, Fu P, Wang L, Xiang C. Mitochondria: potential targets for osteoarthritis. Front. Med., 2020, 7 581402

[22] Minguzzi Met al.. Emerging players at the intersection of chondrocyte loss of maturational arrest, oxidative stress, senescence and low-grade inflammation in osteoarthritis. Oxid. Med. Cell. Longev., 2018, 2018 3075293

[23] Yu LLet al.. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J. Gastroenterol., 2004, 10: 3255-3260

[24] Fujioka Set al.. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J. Biol. Chem., 2004, 279: 27549-27559

[25] Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J. Clin. Investig., 2005, 115: 2625-2632

[26] Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem., 1999, 274: 30353-30356

[27] Bi Ret al.. A single-cell transcriptional atlas reveals resident progenitor cell niche functions in TMJ disc development and injury. Nat. Commun., 2023, 14 830

[28] Wang Yet al.. The role of IL-1beta and TNF-alpha in intervertebral disc degeneration. Biomed. Pharmacother., 2020, 131 110660

[29] Yao Qet al.. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct. Target. Ther., 2023, 8: 56

[30] Tabeian, H. et al. IL-1beta damages fibrocartilage and upregulates MMP-13 expression in fibrochondrocytes in the condyle of the temporomandibular joint. Int. J. Mol. Sci.20, https://doi.org/10.3390/ijms20092260 (2019).

[31] Ji Qet al.. The IL-1beta/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis. J. Mol. Med., 2016, 94: 771-785

[32] Hu, Q. & Ecker, M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. Int. J. Mol. Sci.22, https://doi.org/10.3390/ijms22041742 (2021).

[33] Jiang Let al.. ADAMTS5 in osteoarthritis: biological functions, regulatory network, and potential targeting therapies. Front. Mol. Biosci., 2021, 8 703110

[34] Liu Xet al.. TLR4 contributes to the damage of cartilage and subchondral bone in discectomy-induced TMJOA mice. J. Cell. Mol. Med., 2020, 24: 11489-11499

[35] Lu Ket al.. Molecular signaling in temporomandibular joint osteoarthritis. J. Orthop. Transl., 2022, 32: 21-27

[36] Wang X, Li F, Fan C, Wang C, Ruan H. Effects and relationship of ERK1 and ERK2 in interleukin-1beta-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes. Int. J. Mol. Med., 2011, 27: 583-589

[37] Goldring MBet al.. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur. Cell Mater., 2011, 21: 202-220

[38] Fan Bet al.. Periostin mediates condylar resorption via the NF-kappaB-ADAMTS5 pathway. Inflammation, 2020, 43: 455-465

[39] Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature, 1998, 396: 77-80

[40] Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb. Vasc. Biol., 2011, 31: 986-1000

[41] Yang D, Xu K, Xu X, Xu P. Revisiting prostaglandin E2: a promising therapeutic target for osteoarthritis. Clin. Immunol., 2024, 260 109904

[42] Ulivi V, Giannoni P, Gentili C, Cancedda R, Descalzi F. p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J. Cell. Biochem., 2008, 104: 1393-1406

[43] Seki H, Fukuda M, Iino M, Takahashi T, Yoshioka N. Immunohistochemical localization of cyclooxygenase-1 and -2 in synovial tissues from patients with internal derangement or osteoarthritis of the temporomandibular joint. Int. J. Oral. Maxillofac. Surg., 2004, 33: 687-692

[44] Derwich, M., Mitus-Kenig, M. & Pawlowska, E. Orally administered NSAIDs-general characteristics and usage in the treatment of temporomandibular joint osteoarthritis—a narrative review. Pharmaceuticals14, https://doi.org/10.3390/ph14030219 (2021).

[45] Almarza AJet al.. Preclinical animal models for temporomandibular joint tissue engineering. Tissue Eng. Part B Rev., 2018, 24: 171-178

[46] Hagandora CK, Almarza AJ. TMJ disc removal: comparison between pre-clinical studies and clinical findings. J. Dent. Res., 2012, 91: 745-752

[47] Raut, R. D. et al. The unique molecular signature of TMJ as compared to the knee, demonstrates its susceptibility to osteoarthritis. J. Oral Biosci.67, https://doi.org/10.1016/j.job.2025.100680 (2025).

[48] Harding O, Holzer E, Riley JF, Martens S, Holzbaur ELF. Damaged mitochondria recruit the effector NEMO to activate NF-kappaB signaling. Mol. Cell, 2023, 83: 3188-3204.e7

[49] Shin, H. J. et al. Pink1-mediated chondrocytic mitophagy contributes to cartilage degeneration in osteoarthritis. J. Clin. Med.8, https://doi.org/10.3390/jcm8111849 (2019).

[50] D’Amico Det al.. Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. Aging Cell, 2022, 21 e13662

[51] Geisler Set al.. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol., 2010, 12: 119-131

[52] Petzold Tet al.. Focal adhesion kinase modulates activation of NF-kappaB by flow in endothelial cells. Am. J. Physiol. Cell Physiol., 2009, 297: C814-C822

[53] Murphy JMet al.. Focal adhesion kinase activity and localization is critical for TNF-alpha-induced nuclear factor-kappaB activation. Inflammation, 2021, 44: 1130-1144

[54] Zhang Cet al.. LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling. Sci. Rep., 2021, 11 17020

[55] Martin Aet al.. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. EMBO J., 2015, 34: 1090-1109

[56] Alshenibr Wet al.. Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis. Arthritis Res. Ther., 2017, 19: 179

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)(R01 DE031413)

RIGHTS & PERMISSIONS

The Author(s)